Tag Archives: Brian Armstrong

19Oct/26

How Billionaires Turn Philanthropy Into Power

Technocratic Capital vs. Traditional Charity: The Billionaire Battle Over Philanthropy

Mon Oct. 19, 2026 /Mpelembe Media/ — Prominent Silicon Valley leaders, most notably Elon Musk and Coinbase CEO Brian Armstrong, have spearheaded a systematic ideological shift away from traditional billionaire philanthropy. Armstrong and Musk argue that conventional non-profit grantmaking and large private foundations are inefficient, prone to administrative bloat, and routinely “captured by ideology,” rendering many charitable endeavors a net negative for society. Rooted in capitalist techno-determinism and Effective Accelerationism (e/acc), this perspective holds that civilizational advancement is best achieved not through non-profit redistribution, but by aggressively deploying private capital into high-risk, engineering-driven for-profit enterprises—such as electric vehicles, space exploration, and digital infrastructure. Consequently, leaders subscribing to this philosophy prioritize market innovation and founder-controlled capital allocation over legacy grantmaking models exemplified by Bill Gates or Warren Buffett. Continue reading →

30Aug/26

Silicon Valley is rebranding eugenics

Scientific Racism’s Secret Backers: How Tech Wealth and Stolen Bio-Data Fuel a Discredited Pseudoscience

Sat Aug 29 2026 /Mpelembe Media/ — The contemporary landscape of reproductive medicine is witnessing the rapid commercialization of polygenic embryo screening (PES), a controversial technology that allows prospective parents to genotypically analyze and prioritize IVF-created embryos based on polygenic risk scores (PRSs). Driven by several well-funded US-based startups, this emerging industry offers to estimate the likelihood of chronic disease liabilities as well as quantitative, non-disease traits like eye color, height, and predicted intelligence. For instance, Orchid Biosciences markets whole-genome embryo sequencing at $2,500 per embryo to assess genetic predispositions to multi-gene health conditions like schizophrenia and cardiovascular diseases. In parallel, Nucleus Genomics has heavily marketed a $30,000 “IVF+” package to screen for over 2,000 traits, leveraging a high-profile New York City subway advertising campaign featuring slogans like “Have Your Best Baby” and “IQ is 50% Genetic”. The most controversial player in this market, Heliospect Genomics, charges wealthy couples up to $50,000 to screen up to 100 embryos for predicted intelligence and other behavioral traits using specialized algorithms. Continue reading →